<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><description>领星是由中美生物医学数据科学家携手高年资肿瘤专家共同开创的临床科技和数据平台，提供肿瘤精准医疗和数据智能服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 14 Feb 2021 16:36:02 +0800</pubDate><image><url>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</url><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>领星祝您牛年畅快笑，平安福星照！</title><link>https://mp.weixin.qq.com/s/yzLTaax1AIrp9KDZl_bpbw</link><description></description><content:encoded><![CDATA[领星祝您牛年畅快笑，平安福星照！]]></content:encoded><pubDate>Wed, 10 Feb 2021 23:07:02 +0800</pubDate></item><item><title>免疫or化疗，MSI-H晚期肠癌患者 一线治疗该如何选择？</title><link>https://mp.weixin.qq.com/s/vWYCWaqixxzQ8-muuCNHww</link><description></description><content:encoded><![CDATA[免疫or化疗，MSI-H晚期肠癌患者 一线治疗该如何选择？]]></content:encoded><pubDate>Mon, 08 Feb 2021 13:24:33 +0800</pubDate></item><item><title>持续收样丨启东领星医学检验实验室春节不打烊！</title><link>https://mp.weixin.qq.com/s/ltmYn-FzZfkg6gD_nxEuBw</link><description></description><content:encoded><![CDATA[持续收样丨启东领星医学检验实验室春节不打烊！]]></content:encoded><pubDate>Sun, 07 Feb 2021 11:01:29 +0800</pubDate></item><item><title>PD-1 抑制剂在不同瘤种中的应用</title><link>https://mp.weixin.qq.com/s/exfmUV-MSv2mqmJdFBj5dA</link><description></description><content:encoded><![CDATA[PD-1 抑制剂在不同瘤种中的应用]]></content:encoded><pubDate>Fri, 05 Feb 2021 15:55:05 +0800</pubDate></item><item><title>世界抗癌日丨如何与癌共舞！（文末有福利）</title><link>https://mp.weixin.qq.com/s/vFYfeAm4MKFlbS_kI8p5qA</link><description></description><content:encoded><![CDATA[世界抗癌日丨如何与癌共舞！（文末有福利）]]></content:encoded><pubDate>Thu, 04 Feb 2021 10:12:53 +0800</pubDate></item><item><title>速递丨拜耳诺倍戈在国内获批！CAR-T展现治疗实体瘤潜力！</title><link>https://mp.weixin.qq.com/s/UoLk0j7mBPA6noqUxs58-A</link><description></description><content:encoded><![CDATA[速递丨拜耳诺倍戈在国内获批！CAR-T展现治疗实体瘤潜力！]]></content:encoded><pubDate>Thu, 04 Feb 2021 10:12:53 +0800</pubDate></item><item><title>临床试验| 晚期或转移性结直肠癌（一）</title><link>https://mp.weixin.qq.com/s/HfgVoQLrh5gD8ZY74X1TTg</link><description></description><content:encoded><![CDATA[临床试验| 晚期或转移性结直肠癌（一）]]></content:encoded><pubDate>Wed, 03 Feb 2021 11:17:45 +0800</pubDate></item><item><title>免疫+靶向药物的强强联合治疗晚期胃癌- 最新研究进展盘点</title><link>https://mp.weixin.qq.com/s/nwF2K9ohAUGJcJgQAHbrhw</link><description></description><content:encoded><![CDATA[免疫+靶向药物的强强联合治疗晚期胃癌- 最新研究进展盘点]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:12:14 +0800</pubDate></item><item><title>速递丨安进Sotorasib二期非小细胞肺癌临床试验成功！</title><link>https://mp.weixin.qq.com/s/Z7repf0vXCtWbhP1aWhZ0w</link><description></description><content:encoded><![CDATA[速递丨安进Sotorasib二期非小细胞肺癌临床试验成功！]]></content:encoded><pubDate>Tue, 02 Feb 2021 10:12:14 +0800</pubDate></item><item><title>星闻丨权威认证！领星医学连续三年满分通过美国CAP室间质评！</title><link>https://mp.weixin.qq.com/s/TKrd1Y7r63TBj6JI8tFGFA</link><description></description><content:encoded><![CDATA[星闻丨权威认证！领星医学连续三年满分通过美国CAP室间质评！]]></content:encoded><pubDate>Fri, 29 Jan 2021 10:18:48 +0800</pubDate></item><item><title>抗PD-1与抗CTLA-4双免治疗，TNF抑制剂或可增效减毒</title><link>https://mp.weixin.qq.com/s/9VyoC3erLhvZvHL9swWtug</link><description></description><content:encoded><![CDATA[抗PD-1与抗CTLA-4双免治疗，TNF抑制剂或可增效减毒]]></content:encoded><pubDate>Thu, 28 Jan 2021 11:50:51 +0800</pubDate></item><item><title>速递丨全球首个申报临床的BTK-PROTAC来了</title><link>https://mp.weixin.qq.com/s/POOsPnfAEvuo38gsuDpqhQ</link><description></description><content:encoded><![CDATA[速递丨全球首个申报临床的BTK-PROTAC来了]]></content:encoded><pubDate>Thu, 28 Jan 2021 11:50:51 +0800</pubDate></item><item><title>临床试验| 晚期或转移性尿路上皮癌（四）</title><link>https://mp.weixin.qq.com/s/vyT_DlIrHztW5IGUCIVUpw</link><description></description><content:encoded><![CDATA[临床试验| 晚期或转移性尿路上皮癌（四）]]></content:encoded><pubDate>Wed, 27 Jan 2021 16:48:08 +0800</pubDate></item></channel></rss>